- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03056469
Patient-Reported Outcomes Integrated in the Follow-up of Patients With Hematological Cancer
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a multimethod study. It has a quantitative and a qualitative part. The patient-reported outcome questionnaire European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ C-30) and the patient-reported outcome and patient-reported experience questionnaire The Outcomes and Experiences Questionnaire (OEQ) are completed by the included patients within one week before a patient-physician consultation at the outpatient clinic at one single department of hematology. Baseline is different for different patient groups; 1) for participants receiving a primary treatment baseline is defined as the first patient-physician consultation after the primary treatment ended, 2) for patients continuously receiving medical treatment baseline is defined as the first patient-physician consultation after starting medical treatment, and 3) for patients followed using a watch and wait strategy baseline is defined as the first patient-physician consultation after deciding the watch and wait strategy. Each patient completes the questionnaires for 2 years. The questionnaires can be completed online or on paper depending on the patients choice. Answers from both questionnaires are eligible to all health care professionals in the outpatient clinic in an internet-based tool. A summary of scores from the EORTC QLQ C-30, and the answers and the score from the OEQ, are written in the medical record.
This study investigates, if use of the patient-reported outcome (PRO) questionnaires are useful in the assessment of the patients needs and health care providers decision making regarding supportive care interventions. It investigates, if completion of PRO questionnaires changes the number and kind of supportive care interventions.
Observations of patient-physician consultations and individual interviews with patients are used to capture the impact of the questionnaires on the consultations and patients evaluation of the use of the questionnaires.
This study also investigates, if patients completion of PRO questionnaires and health care professionals use of the questionnaires in clinical decision making changes the number of contacts between patients and a department of hematology and the number of paraclinical interventions.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nana Brochmann, MD
- Phone Number: +4522833458 +4522833458
- Email: nmor@regionsjaelland.dk
Study Contact Backup
- Name: Hans Hasselbalch, professor
- Phone Number: +4526223678 +4526223678
- Email: hans.hasselbalch@gmail.com
Study Locations
-
-
Zealand
-
Roskilde, Zealand, Denmark, 4000
- Recruiting
- Department of Hematology, Zealand University Hospital
-
Contact:
- Nana Brochmann, MD
- Phone Number: +4522833458 +4522833458
- Email: nmor@regionsjaelland.dk
-
Contact:
- Hans Hasselbalch, professor
- Phone Number: +4526223678 +4526223678
- Email: hans.hasselbalch@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients newly diagnosed with not curable, chronic hematological cancer
- ≥18 years old
- oral and written informed consent
Exclusion Criteria:
- participation in another intervention study
- psychological or physiological conditions that may prevent compliance/adherence to the study
- patients do not wish to be included in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Care providers do have access to PROs
Participants complete patient-reported outcome (PRO) questionnaires.
Care providers do have access to the PROs and use them in clinical decision making.
|
Patient-reported outcome (PRO) questionnaires are completed at home within one week before a patient-physician consultation at the outpatient clinic.
The questionnaires are submitted online or on paper depending on the participants choice.
|
Active Comparator: Care providers do not have access to PROs
The participants complete patient-reported outcome (PRO) questionnaires.
Care providers do not have access to the PROs.
|
Patient-reported outcome (PRO) questionnaires are completed at home within one week before a patient-physician consultation at the outpatient clinic.
The questionnaires are submitted online or on paper depending on the participants choice.
|
No Intervention: Control group
Standard follow-up.
The participants do not complete PRO questionnaires.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Supportive care interventions
Time Frame: Three and a half year
|
Number and kind of supportive care interventions are registered.
Supportive care actions are defined as: a) a plan for rehabilitation, b) an intervention by a physiotherapist, occupational therapist, dietician, or social worker, c) consultation with a psychologist or talk with a priest, d) an intervention done by a general practitioner because of the hematological cancer after contact between the hematological department and the general practitioner, e) use of offers like group talks etc offered by the Danish Cancer Society, or f) other supportive care interventions
|
Three and a half year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patients satisfaction with the interventions done by a department of hematology
Time Frame: Three and a half year
|
Patients satisfaction with the interventions done by a department of hematology are measured using a patient-reported experience questionnaire
|
Three and a half year
|
Impact of the use of PRO questionnaires on the consultation and patient satisfaction with and evaluation of the use of patient-reported outcomes in the outpatient clinic
Time Frame: Three and a half year
|
The impact of the use of PRO questionnaires on the consultation and patients satisfaction with and evaluation of the use of patient-reported outcomes in the outpatient clinic are investigated by observation of conversations between doctors and patients in the outpatient clinic, and furthermore investigated by individual interviews
|
Three and a half year
|
Contacts to the outpatient clinic at department of hematology
Time Frame: Three and a half year
|
All contacts between the patients and the department of hematology are registered.
Are there more/less/equal number and kind of contacts to the outpatient clinic at department of hematology when using patient-reported outcomes compared to when not using patient-reported outcomes?
|
Three and a half year
|
Paraclinical interventions
Time Frame: Three and a half year
|
All paraclinical actions ordered by the department of hematology are registered.
Are more/less/equal number and kind of paraclinical interventions done when using patient-reported outcomes compared to when not using patient-reported outcomes?
|
Three and a half year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Hans Hasselbalch, professor, Department of Hematology, Zealand University Hospital, Vestermarksvej 9, 4000 Roskilde, Denmark
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- REG-72-2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hematological Cancer
-
University Hospital HeidelbergUniversity of Cologne; University Hospital Freiburg; University Hospital DresdenTerminated
-
Assistance Publique Hopitaux De MarseilleRecruitingCancer and / or Hematological MalignancyFrance
-
Zhongnan HospitalRecruitingA Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic TumorsHematological Malignancy | Cancer-Related AnemiaChina
-
NYU Langone HealthWithdrawnCancer | Hematological MalignancyUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownMetastatic Cancer | Hematological MalignancyFrance
-
Universitair Ziekenhuis BrusselVrije Universiteit BrusselEnrolling by invitationChildhood Cancer | Hematological DisordersBelgium
-
Henrik FrederiksenUnknown
-
University Hospital, MontpellierSoroptimist association of MonacoRecruitingSolid Tumor, Childhood | Pediatric Tumor | Familial Cancer | Hematological TumorFrance
-
Istituto Clinico HumanitasRecruiting
-
UNC Lineberger Comprehensive Cancer CenterTerminatedHematological DisorderUnited States
Clinical Trials on Completion of patient-reported outcome (PRO) questionnaires
-
Regina Elena Cancer InstituteCentro di Riferimento Oncologico - Aviano; Fondazione Salvatore Maugeri; Istituti... and other collaboratorsRecruitingQuality of Life | Psychological Distress | Breast Neoplasm FemaleItaly
-
Maastricht University Medical CenterRecruiting
-
Stanford UniversityCompletedType 2 DiabetesUnited States
-
NYU Langone HealthAgency for Healthcare Research and Quality (AHRQ)Not yet recruiting
-
AmgenCompletedThrombocytopenia | Idiopathic Thrombocytopenic Purpura | Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Thrombocytopenic Purpura
-
AstraZenecaParexelTerminatedNon Small Cell Lung CancerUnited States, Korea, Republic of
-
University Hospital, Basel, SwitzerlandWithdrawnAvascular Necrosis of the Femoral Head
-
Seoul National University HospitalSK Telecom ConsortiumCompleted
-
Olivier CHASSANYBeaujon Hospital; Bichat Hospital; EA 7334, Patient-Centered Outcomes ResearchCompletedEmergency Medicine | Asthma AttackFrance
-
University Paris 7 - Denis DiderotUniversity of Manchester; Hospital Vall d'Hebron; Hôpital Louis Mourier; EA 7334...CompletedIBS - Irritable Bowel Syndrome | General PopulationUnited Kingdom, France, Spain